Top Picks: Accredited Activities

ASCO 2018 Annual Meeting Highlights

Naval Daver, MD; Guillermo Garcia-Manero, MD; Mark J. Levis, MD, PhD; Richard Stone, MD; and Eunice S. Wang, MD

EHA 2018 Annual Congress Highlights in Acute Myeloid Leukemia

Jorge E. Cortes, MD; Mark J. Levis, MD, PhD; Keith W. Pratz, MD; and Eytan M. Stein, MD

Recent Activities by Topic

  • FAQ: CAR T case study in acute myeloid leukemia - D. Sallman, MD (5:49) - Posted 07/03
    podcast
  • FAQ: How are the drugs approved for AML in 2017 changing the therapeutic landscape? - N. Daver, MD - Posted 06/13
    text
  • FAQ: What is the role of emerging targeted therapies in AML? - N. Daver, MD - Posted 06/06
    text
  • VIDEO FAQ: What has been found to be the median time to best response with enasidenib? - H. Carraway, MD (1:22) - Posted 05/23
    video
  • VIDEO: Are IDH2 Inhibitors Right for Your AML Patient? - H. Carraway, MD  (27:10) - Posted 05/15
    CE video
  • Additional activities...
  • VIDEO FAQ: What are the latest guidelines for molecular testing in AML? - J. Patel, MD (1:56) - Posted 07/24
    video
  • VIDEO FAQ: Do I need to re-test patients at relapse who had an IDH mutation at diagnosis? - H. Carraway, MD (1:07) - Posted 05/02
    video
  • CASE: 53-year-old woman presenting with severe fatigue and bruising - J. Khoury, MD (3:57) - Posted 03/21
    audio
  • VIDEO FAQ: The hematopathologist's role in the diagnosis of AML - J. Khoury, MD (7:10) - Posted 12/26
    video
  • Additional activities...

Supporters

MediCom Worldwide, Inc. would like to recognize and thank the following companies for their educational support of Managing AML.com in 2018

  • Agios Pharmaceuticals, Inc.
  • Celgene Corporation
  • Daiichi Sankyo, Inc.
  • Helsinn Healthcare SA
  • Jazz Pharmaceuticals

MediCom Oncology Links

Please visit these other members of the MediCom Oncology family of sites.

Managing MDS Managing Myeloma The Practical Oncologist
Managing Hodgkin Lymphoma Partners in Pancreatic Cancer Emerging Solutions in Pain